Use of Rapid Antigen Triple Test Nasal Swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in Children With Respiratory Symptoms: A Real-life Prospective Study
- PMID: 38173847
- PMCID: PMC10764097
- DOI: 10.1093/ofid/ofad617
Use of Rapid Antigen Triple Test Nasal Swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in Children With Respiratory Symptoms: A Real-life Prospective Study
Abstract
Background: In autumn 2022, the epidemics due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV), and influenza overlapped, and these diseases can present with the same symptomatology. The use of a triple antigen test (SARS-CoV-2 + influenza A/B + RSV) seems crucial for accurate viral diagnosis in the context of implementing long-acting monoclonal antibody vaccination against RSV in the upcoming RSV season.
Methods: We assessed the usefulness of the triple test in real life in this prospective study performed from October 2022 to May 2023 and involving 116 pediatricians (2 emergency department pediatricians and 114 ambulatory pediatricians). Children <15 years old with flu-like illness (with fever), bronchiolitis (dyspnea ± wheezing), otitis, and croup were enrolled and sampled with a nasal triple test.
Results: For 8329 children with flu-like illness (65.3%), bronchiolitis (17.9%), otitis (8.8%), and croup (6.3%), the use of the triple test led to a viral diagnosis in 47.9% of cases. The highest RSV positivity occurred in children with bronchiolitis (32.9%). The highest influenza A and B positivity (24.6% and 19.6%) occurred in children with flu-like illness. A succession of 3 epidemics (RSV and influenza A and B) occurred over time with several overlap periods.
Conclusions: The triple test allowed for a viral diagnosis in half of our cases. The upcoming introduction of RSV prevention will emphasize the need for active surveillance with viral results both in ambulatory settings and hospitals. Clinical Trials Registration. NCT0441231.
Keywords: RSV; children; influenza; rapid antigen test; respiratory tract infection.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. R. C. reports personal fees and nonfinancial support from Pfizer and personal fees from GSK, Merck, Pfizer, and Sanofi, outside the submitted work. C. L. reports personal fees and nonfinancial support from Pfizer and personal fees from MSD, outside the submitted work. All other authors report no potential conflicts.
Figures
Similar articles
-
Diagnostic accuracy of a rapid antigen triple test (SARS-CoV-2, respiratory syncytial virus, and influenza) using anterior nasal swabs versus multiplex RT-PCR in children in an emergency department.Infect Dis Now. 2023 Oct;53(7):104769. doi: 10.1016/j.idnow.2023.104769. Epub 2023 Aug 10. Infect Dis Now. 2023. PMID: 37572988
-
Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2.Microbiol Spectr. 2024 Aug 6;12(8):e0115324. doi: 10.1128/spectrum.01153-24. Epub 2024 Jul 11. Microbiol Spectr. 2024. PMID: 38990032 Free PMC article.
-
Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.J Korean Med Sci. 2021 Dec 13;36(48):e328. doi: 10.3346/jkms.2021.36.e328. J Korean Med Sci. 2021. PMID: 34904407 Free PMC article.
-
Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review.Curr Pediatr Rev. 2023;19(2):139-149. doi: 10.2174/1573396318666220810161945. Curr Pediatr Rev. 2023. PMID: 35950255 Review.
-
Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.Microorganisms. 2025 Jan 2;13(1):63. doi: 10.3390/microorganisms13010063. Microorganisms. 2025. PMID: 39858831 Free PMC article. Review.
Cited by
-
An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future.Immun Inflamm Dis. 2024 Nov;12(11):e70049. doi: 10.1002/iid3.70049. Immun Inflamm Dis. 2024. PMID: 39508631 Free PMC article. Review.
-
Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case-control study.Lancet Reg Health Eur. 2024 Jul 23;44:101007. doi: 10.1016/j.lanepe.2024.101007. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39139197 Free PMC article.
References
-
- American Academy of Pediatrics. COVID testing and kids: what you should know. 2022. Available at: https://www.healthychildren.org/English/health-issues/conditions/COVID-1.... Accessed 28 December 2023.
-
- Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity—a strategy for containment. N Engl J Med 2020; 383:e120. - PubMed
-
- World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection. 2021. Available at: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnos.... Accessed 2 March 2023.
-
- Centers for Disease Control and Prevention. What to know about COVID-19 testing in schools. 2019. Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html. Accessed 28 December 2023.
LinkOut - more resources
Full Text Sources
Miscellaneous